Clotting Factors, Kininogens, and Complement Components
Eosinophil
Basophil
Connective Tissue Matrix:
Elastic Fibers
Collagen Fibers
Proteoglycans
The components of acute and chronic inflammatory responses consist of both circulating cells and proteins, cells within blood vessels, and those of the extracellular matrix.
Cellular Events of Inflammation
Critical Function of Inflammation: Delivery of White Blood Cells (WBCs) to the injury site.
Process: Known as Extravasation, which involves three main steps:
Margination, Rolling and Adhesion: WBCs contact and adhere to the endothelium.
Transmigration: WBCs pass through the endothelium (termed diapedesis).
Migration: Movement in interstitial tissues toward an injury site, guided by chemotactic stimuli.
Sequence of Events in Leukocyte Emigration
Overview of leukocyte emigration during inflammation:
Laminar blood flow pushes leukocytes against the venular wall, increasing interaction.
Stages of Leukocyte Movement:
Rolling: Leukocytes roll along the endothelium.
Arrest and Adhesion: Leukocytes adhere firmly to the endothelium.
Transmigration: Leukocytes pass through interendothelial junctions and penetrate the basement membrane.
Migration: Guided toward chemoattractants released from injury sites.
Effects of Blood Flow: Loss of fluid increases blood viscosity, aiding in leukocyte contact with endothelial surfaces.
Mechanisms of WBC Adhesion & Transmigration
Adhesion Process: WBC adhesion and transmigration depend on interactions between adhesion molecules on WBCs and endothelial cells:
Selectins (E, P & L): Located on endothelial cells, they bind to WBC receptors, facilitating rolling and adhesion.
Integrins: Found on WBCs, they bind to surface immunoglobulins and extracellular matrix components, attracting WBCs without needing direct contact with endothelium.
Immunoglobulin Molecules: Surface adhesins on endothelium which bind to integrins on WBCs promote stable adhesion and transmigration.
Modulation of WBC Adhesion
Chemotactic Agents and Cytokines: Influence WBC adhesion and transmigration by:
Redistributing preformed adhesion molecules to endothelial surfaces.
Inducing new adhesion molecules on endothelial surfaces, thereby enhancing WBC adhesion.
Increasing adhesion molecule avidity: Initially, integrins have low binding affinity, but on activation, revert to a high-affinity state that strengthens adhesion.
Examples of Chemotactic Agents
For Polymorphonuclear Leukocytes (PMNs):
Bacterial Products
C5a
Arachidonic Acid Metabolites: Including LTB4, HETE, kallikrein.
Process of Chemotaxis
Chemotaxis involves specific steps:
Binding of chemotactic agents to receptors on WBCs.
Resulting Increase in cytosolic calcium (Ca2+).
Activation of GTPase activity enhancing the polymerization of actin, facilitating cell migration.
Leukocyte Activation
Activation Mechanisms induced by chemotactic agents:
Production of Arachidonic Acid Metabolites.
Release of Lysosomal Enzymes.
Cytokine Secretion: Expanding the inflammatory response.
Increased Expression of Adhesion Molecules.
Biochemical Events in Leukocyte Activation
Process includes:
Receptor-Ligand Binding leading to G protein activation.
Phospholipase C Activation: Cleaving phosphatidylinositol bisphosphate (PIP2) to produce inositol triphosphate (IP3) + diacylglycerol (DAG).
Conditions like diabetes impair various aspects of WBC function including chemotaxis and phagocytosis.
Termination of Acute Inflammatory Response
Acute inflammation is tightly regulated:
Short-lived mediators with rapid pulses ensure the control of inflammation.
Activation of both Start Signals and Stop Signals occurs concurrently; thus, as harmful molecules diminish, counteracting molecules can continue to be produced, ensuring normal tissue is preserved from damage.
Conclusions
WBC adhesion, arrest, and transmigration rely on the interaction between selectins (produced by endothelium) and integrins (on WBC surfaces).
Chemokines and cytokines influence adhesion and transmigration by altering generation and avidity of adhesion molecules.
PMN processes—adhesion and transmigration—occur in a sequential manner involving:
Endothelial activation.
Leukocyte rolling and stable adhesion.
Finally, effective transmigration.
Chemotaxis is driven by endogenous and exogenous products binding to WBCs facilitating structural changes necessary for migration.
PMNs predominate early due to rapid response and migratory efficiency.
Release of WBC products can lead to tissue damage, pertinent to understanding acute inflammation.
Various genetic and acquired dysfunctions impact WBC roles in inflammation, including conditions such as diabetes that complicate outcomes.